Ligand · ALJ
ALJ · Cyclo-(L-arginine-L-proline) inhibitor
ALJ, Cyclo-(L-arginine-L-proline) inhibitor (C11 H19 N5 O2, 253.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the…
- Component
- ALJ
- Formula
- C11 H19 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
ALJ in 2 structures; the first of them:
- 1W1V · Crystal structure of S. marcescens chitinase B in complex with the cyclic dipeptide… · ALJ A1520 · binds TYR10, PHE51, GLY96, TRP97, ASP142, GLU144, ALA184, MET212 and 7 more
- 1W1V · Crystal structure of S. marcescens chitinase B in complex with the cyclic dipeptide… · ALJ A1520 · binds TYR10, PHE51, GLY96, TRP97, ASP142, GLU144, ALA184, MET212 and 7 more
Residues it binds most
TYR 4, ASP 4, MET 4, TRP 4, ALA 4, ARG 4, GLU 4, GLY 4, ILE 4, PHE 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.